Tech Company Financing Transactions
OyaGen Funding Round
University of Rochester Medical Center joined a $100 thousand Series A funding round for OyaGen. The round was announced on 10/22/2008.
Transaction Overview
Company Name
Announced On
10/22/2008
Transaction Type
Venture Equity
Amount
$100,000
Round
Series A
Investors
University of Rochester Medical Center (Robert Bambara)
Proceeds Purpose
This initial set of grants, provided to scientists in 22 countries, was chosen to inject fresh perspective into research seeking to prevent or cure infectious diseases such as HIV/AIDS and tuberculosis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
77 Ridgeland Rd. 151
Henrietta, NY 14623
USA
Henrietta, NY 14623
USA
Phone
Website
Email Address
Not Recorded
Overview
OyaGen is a biotechnology company formed on September 5, 2003, for the purpose of discovering, developing, and commercializing novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harold Smith
Chief Financial Officer
Kevin Phelps
Chief Operating Officer
Thomas Fitzgerald
Browse more venture capital transactions:
Prev: 10/22/2008: AMEC venture capital transaction
Next: 10/22/2008: VasoLux MicroSystems venture capital transaction
Share this article
News on VC Transactions
We report on funding rounds that are announced publicly. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs